CSRxP Applauds National Governors Association’s Commitment to Lowering Drug Prices
May 31, 2019
NGA’s “2019 Principles for Federal Action to Address Health Care Costs”… Read More
© 2025 CSRXP- All Rights Reserved
Updates
CSRxP Appreciates HELP Leaders’ Bipartisan Commitment to Lowering Drug Prices
May 23, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released… Read More
THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices
May 22, 2019
Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on… Read More
Lawmakers Keeping Up Bipartisan Momentum On Drug Pricing
May 21, 2019
House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
May 18, 2019
Part IV: Big Pharma’s Tax Conundrum The average American spends $1… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
May 17, 2019
Part III: As Prices Rise, So Too Does Ad Spending The average American… Read More
CSRxP: House Passage of Bipartisan CREATES Act a Pivotal Moment for Patients
May 16, 2019
Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
May 16, 2019
Part II: An Industry Booming Off of Price-Gouging The average American spends… Read More
CSRxP Encourages U.S. House of Representatives to Pass Bipartisan CREATES Act
May 16, 2019
Commends Lawmakers of Both Parties for Working Together to Advance Key Drug… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
May 15, 2019
Part I: The Math Undercuts the R&D Defense The average American spends… Read More
CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency
May 14, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D
May 14, 2019
Analysis Finds Industry Spending on Advertising, Overhead and Profits More… Read More